Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma ( DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial

被引：9

作者：

Casulo, Carla ^{[1
]}

Santoro, Armando ^{[2
,3
]}

Ando, Kiyoshi ^{[4
]}

Le Gouill, Steven ^{[5
]}

Ruan, Jia ^{[6
]}

Radford, John ^{[7
,8
]}

Arcaini, Luca ^{[9
,10
]}

Pinto, Antonello ^{[11
]}

Bouabdallah, Reda ^{[12
]}

Izutsu, Koji ^{[13
]}

Rule, Simon ^{[14
]}

Munoz, Javier ^{[15
]}

Casadebaig, Marie-Laure ^{[16
]}

Fox, Brian ^{[17
]}

Rettby, Nils ^{[16
]}

Dell'Aringa, Justine ^{[17
]}

Delarue, Richard ^{[16
]}

Newhall, Kathryn ^{[17
]}

Czuczman, Myron ^{[17
]}

Cartron, Guillaume ^{[18
]}

机构：

[1] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA

[2] Humanitas Univ, Rozzano Milan, Italy

[3] Humanitas Clin & Res Ctr, Rozzano Milan, Italy

[4] Tokai Univ, Sch Med, Isehara, Kanagawa, Japan

[5] CHU Nantes, Nantes, France

[6] Weill Cornell Med, New York, NY USA

[7] Univ Manchester, Manchester, Lancs, England

[8] Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

[9] Fdn IRCCS Policlin San Matteo, Pavia, Italy

[10] Univ Pavia, Pavia, Italy

[11] Fdn G Pascale, Ist Nazl Tumori IRCCS, Naples, Italy

[12] Inst Paoli Calmettes, Marseille, France

[13] Natl Canc Ctr, Dept Hematol, Tokyo, Japan

[14] Univ Plymouth, Plymouth, Devon, England

[15] Banner MD Anderson Canc Ctr, Gilbert, AZ USA

[16] Celgene Int, Boudry, Switzerland

[17] Celgene Corp, Seattle, WA USA

[18] Ctr Hosp Univ Montpellier, Montpellier, France

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5320

引用

页数：5